Cancer Treatment Market Research Reports & Industry Analysis
Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.
With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.
Cancer Treatment Industry Research & Market Reports
-
Biliary Tract Cancers (BTCs) - Market Insight, Epidemiology And Market Forecast - 2034
... RR-FL; however, follow-up remains limited. Identifying appropriate patients for CAR T-cell therapy stands out as a paramount challenge, given its expensive nature and aggressive treatment approach. The FDA has approved four CAR-Ts in different subtypes ... Read More
-
HER2 Negative Breast Cancer- Pipeline Insight, 2024
... the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this ... Read More
-
Cancer Biomarker Global Market Report 2024
... Cancer; Thyroid Cancer; Kidney Cancer4) By Application: Diagnostics; Research And Development; Prognostics; Risk AssessmentCovering: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; QIAGEN NV; Illumina Inc.; Bio-Rad Laboratories Inc. Cancer Biomarker Global Market Report 2024 ... Read More
-
CAR T-Cell Therapy for Non-Hodgkin's lymphoma (NHL) - Market Insight, Epidemiology And Market Forecast - 2032
... for approximately USD 1,300 million, which is further expected to increase by 2034. Epidermolysis bullosa simplex (EBS) is the least severe type of epidermolysis bullosa, and many individuals with EBS may experience improvements as they ... Read More
-
Prevention and Treatment of Prostate Cancer: Technologies and Global Markets
... recommendations for the success of market participants. The scope of the study is global. This report estimates market data for 2022 (the base year) and provides forecasts for 2023 through 2028. Figures for 2023 are ... Read More
-
Asia-Pacific EV-Based Liquid Biopsy Market: Analysis and Forecast, 2023-2032
... at a CAGR of 21.64% during the forecast period. The market for EV-based liquid biopsy is anticipated to see growth propelled by continuous technological progress, rising acceptance by healthcare providers, and an increasing emphasis on ... Read More
-
Acute Myeloid Leukemia Market - By Disease (Myeloblastic, Myelomonocytic, Promyelocytic), Treatment (Chemotherapy, Targeted Therapy), Route of Administration (Oral, Parenteral), End-user (Hospital, Clinic, Specialty Center) & Forecast 2024 - 2032
... will grow at 10.7% CAGR from 2024 to 2032, propelled by regulatory approvals for novel drugs and therapies for the disease treatment. Rapid advancements in treatment options and the ongoing R&D efforts are providing patients ... Read More
-
Absorbable Tissue Spacer Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... in 2024 to USD 725.76 million by 2029, at a CAGR of 16.79% during the forecast period (2024-2029). The COVID-19 pandemic affected healthcare systems globally and resulted in the interruption of usual care in many ... Read More
-
Thailand Medical Cannabis Market Report by Cultivated Species (Indica, Sativa, Hybrid), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC), and Others), Application Areas (Cancer, Arthritis, Migraine, Epilepsy, and Others), End-Use (Pharmaceuticals, Research and Development Centres, and Others), Route of Administration (Oral Solutions and Capsules, Vaporizers, Topicals, and Others) 2024-2032
... of Administration (Oral Solutions and Capsules, Vaporizers, Topicals, and Others) 2024-2032 The Thailand medical cannabis market size reached US$ 187.1 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 6,328.2 Million ... Read More
-
Non-muscle Invasive Bladder Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middl
... and Africa) The global non-muscle invasive bladder cancer therapeutics market reached a valuation of US$ 2.8 billion in 2024. The market is forecasted to progress to reach US$ 9.2 billion by the end of 2031. ... Read More
-
Regenerative Medicine Market by Product (Stem Cell [Autologous, Allogenic], Immunotherapy, Gene Therapy, Tissue Engineering), Application (Musculoskeletal, Cancer, Dermatology, Wound care, Cardiovascular Diseases, Eye Disorders) - Global Forecast to 2028
... projected to reach USD 49.0 Billion by 2028 from USD 16.0 Billion in 2023, at a CAGR of 25.1% during the forecast period of 2023 to 2028. Factors such as the wide scope in new ... Read More
-
Progressive Multifocal Leukoencephalopathy Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and
... Africa) The global progressive multifocal leukoencephalopathy treatment market is set to experience steady growth from 2024 to 2031. Several key insights are driving this growth in the market: Factors Driving Market Growth: • Rising HIV ... Read More
-
Lymphedema Diagnostics Market Report: Trends, Forecast and Competitive Analysis to 2030
... & academic institute markets. The global lymphedema diagnostics market is expected to grow with a CAGR of 6.8% from 2024 to 2030. The major drivers for this market are rising prevalence of chronic illnesses including ... Read More
-
Europe Next-Generation Breast Cancer Diagnostic and Screening Market: Analysis and Forecast, 2023-2032
... billion in 2023 and is expected to reach $2.57 billion by the end of 2032, registering a CAGR of 13.20% during the forecast period 2023-2032. The growth in the next-generation breast cancer diagnostic and screening ... Read More
-
2024 Ghana Clinical Chemistry and Immunodiagnostics Market - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein and TDM Tests
... provides information and analysis not available from any other published source . Clinical Chemistry Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, Apolipoprotein A-1, Apolipoprotein B, AST/SGOT, Beta-Hydroxybutyrate, Bilirubin (Direct), Bilirubin (Total), BNP, BUN (Blood Urea Nitrogen), ... Read More
-
2024 Portugal Clinical Chemistry and Immunodiagnostics Market - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein and TDM Tests
... provides information and analysis not available from any other published source . Clinical Chemistry Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, Apolipoprotein A-1, Apolipoprotein B, AST/SGOT, Beta-Hydroxybutyrate, Bilirubin (Direct), Bilirubin (Total), BNP, BUN (Blood Urea Nitrogen), ... Read More
-
2024 Moldova Clinical Chemistry and Immunodiagnostics Market - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein and TDM Tests
... provides information and analysis not available from any other published source . Clinical Chemistry Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, Apolipoprotein A-1, Apolipoprotein B, AST/SGOT, Beta-Hydroxybutyrate, Bilirubin (Direct), Bilirubin (Total), BNP, BUN (Blood Urea Nitrogen), ... Read More
-
2024 Chile Clinical Chemistry and Immunodiagnostics Market - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein and TDM Tests
... provides information and analysis not available from any other published source . Clinical Chemistry Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, Apolipoprotein A-1, Apolipoprotein B, AST/SGOT, Beta-Hydroxybutyrate, Bilirubin (Direct), Bilirubin (Total), BNP, BUN (Blood Urea Nitrogen), ... Read More
-
2024 Indonesia Clinical Chemistry and Immunodiagnostics Market - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein and TDM Tests
... provides information and analysis not available from any other published source . Clinical Chemistry Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, Apolipoprotein A-1, Apolipoprotein B, AST/SGOT, Beta-Hydroxybutyrate, Bilirubin (Direct), Bilirubin (Total), BNP, BUN (Blood Urea Nitrogen), ... Read More
-
2024 Russia Clinical Chemistry and Immunodiagnostics Market - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein and TDM Tests
... provides information and analysis not available from any other published source . Clinical Chemistry Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, Apolipoprotein A-1, Apolipoprotein B, AST/SGOT, Beta-Hydroxybutyrate, Bilirubin (Direct), Bilirubin (Total), BNP, BUN (Blood Urea Nitrogen), ... Read More
-
2024 United Arab Emirates Clinical Chemistry and Immunodiagnostics Market - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein and TDM Tests
... from LeadingMarketResearch.com provides information and analysis not available from any other published source . Clinical Chemistry Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, Apolipoprotein A-1, Apolipoprotein B, AST/SGOT, Beta-Hydroxybutyrate, Bilirubin (Direct), Bilirubin (Total), BNP, BUN (Blood ... Read More
-
2024 Uruguay Clinical Chemistry and Immunodiagnostics Market - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein and TDM Tests
... provides information and analysis not available from any other published source . Clinical Chemistry Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, Apolipoprotein A-1, Apolipoprotein B, AST/SGOT, Beta-Hydroxybutyrate, Bilirubin (Direct), Bilirubin (Total), BNP, BUN (Blood Urea Nitrogen), ... Read More
-
2024 Haiti Clinical Chemistry and Immunodiagnostics Market - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein and TDM Tests
... provides information and analysis not available from any other published source . Clinical Chemistry Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, Apolipoprotein A-1, Apolipoprotein B, AST/SGOT, Beta-Hydroxybutyrate, Bilirubin (Direct), Bilirubin (Total), BNP, BUN (Blood Urea Nitrogen), ... Read More
-
2024 Romania Clinical Chemistry and Immunodiagnostics Market - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein and TDM Tests
... provides information and analysis not available from any other published source . Clinical Chemistry Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, Apolipoprotein A-1, Apolipoprotein B, AST/SGOT, Beta-Hydroxybutyrate, Bilirubin (Direct), Bilirubin (Total), BNP, BUN (Blood Urea Nitrogen), ... Read More
-
2024 Slovakia Clinical Chemistry and Immunodiagnostics Market - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drug, Cancer, Chemistry, Endocrine, Immunoprotein and TDM Tests
... provides information and analysis not available from any other published source . Clinical Chemistry Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, Apolipoprotein A-1, Apolipoprotein B, AST/SGOT, Beta-Hydroxybutyrate, Bilirubin (Direct), Bilirubin (Total), BNP, BUN (Blood Urea Nitrogen), ... Read More
Research Assistance
